| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |